Get started
Author

Bernard Pereira

The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
2016 · Bernard Pereira, Suet-Feung Chin, et al. · Nature Communications · 1,717
PDF
Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups
2019 · Oscar M. Rueda, Stephen-John Sammut, et al. · Nature · 418
Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer
2016 · Magali Michaut, Suet-Feung Chin, et al. · Scientific Reports · 173
PDF
The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer
2019 · Leticia De Mattos-Arruda, Stephen-John Sammut, et al. · Cell Reports · 114
PDF
Erratum: The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
2016 · Bernard Pereira, Suet-Feung Chin, et al. · Nature Communications · 97
PDF
The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting
2017 · Tesa M. Severson, Denise M. Wolf, et al. · Breast Cancer Research · 73
PDF
Cell-free DNA captures tumor heterogeneity and driver alterations in rapid autopsies with pre-treated metastatic cancer
2021 · Bernard Pereira, Christopher T. Chen, et al. · Nature Communications · 72
PDF
BRCA1‐like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential
2015 · Tesa M. Severson, Justine Peeters, et al. · Molecular Oncology · 67
PDF
Inference of random walk models to describe leukocyte migration
2015 · Phoebe J M Jones, Aaron Sim, et al. · Physical Biology · 27
PDF
Immune Signature Variation in Twins With Clinically Different Recurrent Respiratory Papillomatosis
2020 · Asitha D. L. Jayawardena, Tingyu Liu, et al. · The Laryngoscope · 2
Contribution and clinical relevance of germline variation to the cancer transcriptome
2022 · Bernard Pereira, Emma Labrot, et al. · BMC Cancer · 1
PDF
Abstract B114: A Phase 1/1b study of KAZ954 alone and in combination with spartalizumab (PDR001) and taminadenant (NIR178) in patients with advanced gastrointestinal malignancies
2023 · Devalingam Mahalingam, Chia-Chi Lin, et al. · Molecular Cancer Therapeutics
Supplementary Data from Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia
2023 · Eytan M. Stein, Daniel J. DeAngelo, et al.
Supplementary Data from Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia
2023 · Eytan M. Stein, Daniel J. DeAngelo, et al.
Data from Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia
2023 · Eytan M. Stein, Daniel J. DeAngelo, et al.
Data from Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia
2023 · Eytan M. Stein, Daniel J. DeAngelo, et al.
Genetic variation in twins with vastly different phenotypical expression of recurrent respiratory papillomatosis
2020 · Asitha D. L. Jayawardena, Tingyu Liu, et al. · The Novartis Repository (Novartis)
Abstract GS3-06: Dynamics of breast cancer relapse reveal molecularly defined late recurring ER-positive subgroups: Results from the METABRIC study
2019 · C Curtis, OM Rueda, et al. · Cancer Research
Assessment of a sensitive and specific method to detect ewing sarcoma minimal residual disease inn testicular and ovarian tissue by RT-qPCR (2018)
2018 · L, Chaput, V, Greze, et al. · HAL (Le Centre pour la Communication Scientifique Directe)
Additional file 2: of The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting
2017 · Tesa Severson, Wolf, Denise, et al. · Figshare
Additional file 1: of The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting
2017 · Tesa Severson, Wolf, Denise, et al. · Figshare
Abstract A30: RATHER: High-resolution molecular profiling of invasive lobular breast cancers
2016 · Suet-Feung Chin, Magali Michault, et al. · Molecular Cancer Research
Abstract B020: A copy number and expression based classifier for breast cancer tumors
2013 · Oscar M. Rueda, Raza H. Ali, et al. · Molecular Cancer Research
Abstract B017: A targeted sequencing approach to characterize the mutational profiles of 178 genes in 2600 primary breast tumors
2013 · Bernard Pereira, Suet-Feung Chin, et al. · Molecular Cancer Research
METABRIC Expression Data
2012 · Curtis, Christina, Pereira, Bernard, et al. · Zenodo (CERN European Organization for Nuclear Research)
Works count: 37
Citation count: 2,765
H-index: 9
I10-index: 9
Year
Topic
Type